首页 | 本学科首页   官方微博 | 高级检索  
     

吸入糖皮质激素治疗稳定期COPD疗效观察
引用本文:林少芳,曹鹰,杜海燕. 吸入糖皮质激素治疗稳定期COPD疗效观察[J]. 临床肺科杂志, 2009, 14(6): 778-779
作者姓名:林少芳  曹鹰  杜海燕
作者单位:昆明市第一人民医院干疗科,云南,650011;昆明市第一人民医院干疗科,云南,650011;昆明市第一人民医院干疗科,云南,650011
摘    要:目的探讨吸入糖皮质激素治疗稳定期慢性阻塞性肺疾病(COPD)患者的疗效。方法将稳定期COPD患者随机分为两组,实验组在常规治疗基础上吸入糖皮质激素布地奈德,对照组仅采用常规治疗,疗程均半年。结果实验组呼吸困难评分、6min步行距离、生活质量评分、第1秒用力呼气等指标均较对照组明显改善(P〈0.05),且急性加重患者的门诊和住院人次较对照组少(P〈0.05)。结论吸入中等量糖皮质激素布地奈德可减轻稳定期COPD患者的临床症状,改善活动耐力、生活质量和肺功能,减少急性加重次数。

关 键 词:糖皮质激素  慢性阻塞性肺疾病  功能改善

The therapeutic effects of inhaling glucocorticoid in patients with stable COPD
Lin Shao-fang,Cao Ying,Du Hai-yan. The therapeutic effects of inhaling glucocorticoid in patients with stable COPD[J]. Journal of Clinical Pulmonary Medicine, 2009, 14(6): 778-779
Authors:Lin Shao-fang  Cao Ying  Du Hai-yan
Affiliation:(Division of Disease Treatment for Government Officials. Kunming First People's Hospital, Yunnan Province Kunming 650011,China)
Abstract:Objective To investigate the curative effects of inhaling glucocorticoid in patients with stable COPD.Methods Patients with stable COPD were randomly divided into 2 groups. The testing group was treated with inhaling glucocorticoid Budesonide based on routine therapy and the contrast group was treated only by routine therapy. The course of treatment was half a year.Results Patients in the testing group were significantly improved more than the contrast one on the measures of decompensation grade 6min walkin...
Keywords:glucocorticoid  COPD  function improvement  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号